In the News with GMI
In the News
Migraines and Memory Loss: How Clinical Trials Are Offering New Hope
Chronic migraines don’t just cause debilitating pain—they may also impact memory and cognitive function. Emerging research highlights a connection between migraines and memory loss, sparking
How Clinical Trials Are Pushing the Boundaries in Dementia Research
Clinical trials are revolutionizing dementia research, offering new hope through innovative treatments, early detection strategies, and personalized medicine. By addressing the complexities of neurodegenerative diseases,
How Clinical Research is Improving PTSD Treatments in 2025
Post-Traumatic Stress Disorder (PTSD) remains a significant mental health challenge, affecting millions of individuals worldwide. In 2025, groundbreaking advancements in clinical research are revolutionizing how
How Clinical Trials Are Shaping the Future of ADHD and PTSD Treatments
Clinical trials are driving significant advancements in the treatment of ADHD and PTSD, offering promising solutions for more effective and individualized care. Through rigorous testing
Innovative Therapies for Depression Management
Emerging therapies are paving the way for more effective depression management. One such approach is transcranial magnetic stimulation (TMS), which uses magnetic fields to stimulate
Migraine Aura and Its Impact on Daily Life
Migraine aura is a disruptive and often debilitating neurological phenomenon that affects many individuals who suffer from migraines. Characterized by visual disturbances such as flashing
